Related Experiment Video
Updated: May 7, 2026
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Effect of an integrated mHealth supportive care program on symptom burden and self-efficacy in post-treatment breast
Yingjie Yao1, Xiangyu Liu2, Yuansi Huang3
1Xiangya School of Nursing, Central South University, Changsha, China.
Purpose:
This randomized controlled trial evaluated the efficacy of a multidisciplinary, mobile health (mHealth) supportive care program designed to alleviate symptom burden and enhance self-efficacy in post-treatment breast cancer survivors (BCS). Secondary outcomes included quality of life (QoL), coping strategies, and inflammatory biomarkers.
Methods:
We conducted a single-blind, randomized controlled trial involving 108 BCS. Participants were allocated to either a 3-month mHealth intervention (n = 54) delivered via the "ThrivePath" app or a routine care control group (n = 54). The app provided structured symptom monitoring, educational resources, and personalized support. Outcomes were assessed at baseline, 3 months (post-intervention), and 6 months (follow-up) and analyzed using linear mixed models.
Results:
Compared to controls, the intervention group showed a significant reduction in symptom burden (β = -9.44, p < 0.001) and a significant increase in self-efficacy (β = 5.45, p < 0.001). The program also improved QoL, enhanced confrontation coping, and led to a significant reduction of pro-inflammatory cytokines (IL-1β, IL-2, IL-6, TNF-α) while preserving anti-inflammatory IL-10 levels.
Conclusions:
The "ThrivePath" mHealth program is an effective, scalable intervention for post-treatment breast cancer survivors. It significantly reduces symptom burden and modulates inflammatory processes while boosting self-efficacy, offering an evidence-based model for delivering comprehensive survivorship care.
Implications For Cancer Survivors:
The ThrivePath program provides a practical and accessible tool for survivors to manage their health following active treatment. By facilitating access to evidence-based resources and enabling direct communication with a care team, the program can help alleviate persistent symptoms, build confidence in self-management, and improve overall quality of life during the transition to survivorship.
Trial Registration:
ChiCTR2500108128.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
01:21Cancer Survival Analysis